glp 1 no longer working “GLP-1s just prove people don’t want to work for it.” Nope. , For those battling strong hunger, trauma, food noise, and biology One of the biggest misconceptions

An estimated 15 million Americans are currently taking semaglutide weight loss drugs, which are proven to impact alcohol consumption

Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity

Weight loss is known to trigger compensatory biology: Increased appetite signaling Reduced resting energy expenditure Heightened food reward sensitivity Stopping GLP-1 therapy at peak dose, without tapering and without reinforcing lifestyle strategies at the exact moment hunger returns, does not allow lifestyle behaviors to take over. Emerging real-world data and obesity physiology suggest a different, more clinically relevant path: Gradual dose reduction rather than abrupt cessation Continued, structured dietary and exercise support Active monitoring during the high-risk post-cessation period We still need randomized trials designed specifically to test tapering and lifestyle-anchored maintenance strategies

Find the cheapest prices on this KIND Weight-Loss GLP-1 Patches 30 pcs on Klarna

Design A retrospective propensity score-matched cohort study was conducted

While the effectiveness of these weight management medications is impressive, they dont come without side effects and one of the most overlooked, yet impactful, is dehydration